Clinical Microbiomics, Symbion
Clinical Microbiomics, Symbion is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis)
Sponsor Biocodex
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomised controlled trial of a moisturiser for treatment of dry skin in atopic dermatitis: effect on the skin barrier in adults with a history of eczema
Sponsor ACO Hud Nordic AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Clinical Microbiomics, Symbion?
The 2026-10-09 snapshot links Clinical Microbiomics, Symbion to 2 distinct CTIS trials. Recorded services include Laboratory services, Medical writing. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Clinical Microbiomics, Symbion?
The most frequently recorded therapeutic areas are Gastroenterology, Infectious Disease. Recorded phases include Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Clinical Microbiomics, Symbion conducted?
The linked trials record locations in 5 countries, including Czechia, Germany, Lithuania, Slovenia, Slovakia. These are trial locations, not confirmed office locations or countries where Clinical Microbiomics, Symbion delivered services.
What can this page tell me about Clinical Microbiomics, Symbion's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Clinical Microbiomics, Symbion. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Clinical Microbiomics, Symbion